Official Title
COVID-19 RELATED SUBMISSION: VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease
Brief Summary

To assess blood levels of vasoactive mediators that may regulate pulmonary endothelial permeability and contribute to multi-organ injury in patients with COVID-19 disease and to correlate the levels of these mediators with disease outcomes such as ICU admission, length of ventilatory support, respiratory failure, kidney failure, heart failure, and death.

Detailed Description

When patients are sick with other lung infections (pneumonias) caused by viruses or bacteria
there are changes in a pathway that regulates the "leakiness" the tiny airspaces inside the
lungs. Even bigger changes in this pathway are seen when patients develop severe breathing
difficulties (acute respiratory distress syndrome) similar to what is seen in patients who
get really sick with COVID-19 disease.

There are important changes in this pathway that occur in patients who have preexisting
cardiovascular (heart) disease who do not have lung infections. The investigator will
evaluate these levels in patients with COVID-19 because the investigator believes that this
baseline difference in pathway regulation may be one reason patients with heart disease who
contract COVID-19 get sicker than patients without heart or vascular disease.

The investigator will also assess the levels of components of this pathway in patients who
are less sick with those who became sick enough to require a tube to help them breathe
because this is important to determine if COVID-19 lung disease has a similar effect on this
pathway as other lung infections like flu and bacterial pneumonias.

Recruiting
COVID-19 Disease
Eligibility Criteria

Inclusion Criteria:

- Positive test for COVID-19 (SARS-CoV-2 infection)

- >=18 years

- Blood (plasma) specimen(s) available in the CCTS biorepository

Exclusion Criteria:

- <18 years

- Lack of blood specimen

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
United States
Locations

University of Alabama at Birmingham
Birmingham, Alabama, United States

Investigator: Dylan Addis, MD
Contact: 919-812-5107
dylanaddis@uabmc.edu

Contacts

Dylan Addis, MD
919-812-5107
dylanaddis@uabmc.edu

Shanna H Graves
205-975-2845
shannagraves@uabmc.edu

Dylan Addis, MD, Principal Investigator
University of Alabama at Birmingham

University of Alabama at Birmingham
NCT Number
Keywords
Covid-19
SARS-CoV-2 viral infection
VEGF and sFlt-1 levels
MeSH Terms
COVID-19